AeroClean Technologies up as FDA allows air purifier use against COVID
** AeroClean Technologies AERC.O shares rise 5.6% to $4
before the bell
** U.S. FDA allows AERC air purifier for use in elimination
of virus that causes COVID-19 in indoor setting urn:newsml:reuters.com:*:nGNXXTMhH
** Permission granted after testing AERC air purifier's
efficacy against the Omicron COVID variant - co
** Up to Tuesday's close, stock had fallen ~64% YTD
(Reporting by Khushi Mandowara)
((Khushi.Mandowara@thomsonreuters.com;))
Recent news on Molekule
See all newsBrief: Molekule Group Inc Received Notice From Nasdaq Notifying Delisting of Common Stock
Brief: Molekule Group Says Co, Molekule Inc Failed To Maintain Unrestricted And Unencumbered Cash With Svb Of At Least $2 Mln, Event Of Default Under Loan Deals
Brief: Molekule Group Inc On September 18 Commenced A Plan To Reduce Company's Headcount By Approximately 15%
Brief: Molekule Group Says It Is Exploring Various Capital Raising Opportunities, Including Rights Offering
U.S. STOCKS ON THE MOVE-Nu Holdings, United States Steel, Mallinckrodt